Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Nanowire Sensors To Be Used for POC Disease Detection

By LabMedica International staff writers
Posted on 22 Oct 2008
Nanowire sensors coupled with simple microprocessor electronics are sensitive and specific enough to be used for point-of-care (POC) disease detection.

The sensors use activation of immune cells by highly specific antigens--signatures of bacteria, viruses, or cancer cells--as the detector. More...
When T cells are activated, they produce acid, and generate a tiny current in the nanowire electronics, signaling the presence of a specific antigen. The system can detect as few as 200 activated cells.

In earlier studies, scientists demonstrated that the nanowires could detect generalized activation of this small number of T-cells. A new report, in the October 1, 2008, issue of the journal Nano Letters, expands that work and shows the nanowires can identify activation from a single specific antigen even when there is substantial background "noise” from a general immune stimulation of other cells.

The report's senior author, Dr. Tarek Fahmy, assistant professor of biomedical engineering at Yale University (New Haven, CT, USA), described the system, "Imagine I am the detector in a room where thousands of unrelated people are talking--and I whisper, ‘Who knows me?' I am so sensitive that I can hear even a few people saying, ‘I do' above the crowd noise. In the past, we could detect everyone talking--now we can hear the few above the many.”

The investigators suggest that in a clinic, assays could immediately determine which strain of flu a patient has, whether or not there is an HIV infection, or what strain of tuberculosis or coli bacteria is present. Currently, there are no electronic POC diagnostic devices available for disease detection. "Instruments this sensitive could also play a role in detection of residual disease after antiviral treatments or chemotherapy,” said Dr. Fahmy. "They will help with one of the greatest challenges we face in treatment of disease--knowing if we got rid of all of it.”

Related Links:
Yale University



New
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Automatic Hematology Analyzer
LABAS F9000
New
Rapid Test Reader
DIA5000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Pathology

view channel
Image: Virtual staining of label-free tissue in imaging mass spectrometry (Photo courtesy of Ozcan Lab/UCLA)

Deep Learning Advances Imaging Mass Spectrometry with Virtual Histological Detail

Imaging mass spectrometry (IMS) is a powerful technique that can map thousands of molecular species in biological tissues with exceptional chemical specificity. However, IMS is hindered by relatively low... Read more

Industry

view channel
Image: Alzheimer’s Association has released its first clinical practice guideline for blood-based biomarker tests (Photo courtesy of Alzheimer’s Association)

New Clinical Guidelines Recommend Use of Blood Tests Instead of Brain Scans for Alzheimer’s Diagnosis

Alzheimer’s disease is a progressive neurodegenerative condition that remains challenging to diagnose early and accurately, particularly in individuals with cognitive impairment. Despite the availability... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.